636 related articles for article (PubMed ID: 25799881)
21. Wnt signaling as potential therapeutic target in lung cancer.
Yang J; Chen J; He J; Li J; Shi J; Cho WC; Liu X
Expert Opin Ther Targets; 2016 Aug; 20(8):999-1015. PubMed ID: 26882052
[TBL] [Abstract][Full Text] [Related]
22. Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer.
Qu Y; Olsen JR; Yuan X; Cheng PF; Levesque MP; Brokstad KA; Hoffman PS; Oyan AM; Zhang W; Kalland KH; Ke X
Nat Chem Biol; 2018 Jan; 14(1):94-101. PubMed ID: 29083417
[TBL] [Abstract][Full Text] [Related]
23. Phenethyl isothiocyanate inhibits colorectal cancer stem cells by suppressing Wnt/β-catenin pathway.
Chen Y; Li Y; Wang XQ; Meng Y; Zhang Q; Zhu JY; Chen JQ; Cao WS; Wang XQ; Xie CF; Li XT; Geng SS; Wu JS; Zhong CY; Han HY
Phytother Res; 2018 Dec; 32(12):2447-2455. PubMed ID: 30159926
[TBL] [Abstract][Full Text] [Related]
24. The Wnt/β-catenin signaling/Id2 cascade mediates the effects of hypoxia on the hierarchy of colorectal-cancer stem cells.
Dong HJ; Jang GB; Lee HY; Park SR; Kim JY; Nam JS; Hong IS
Sci Rep; 2016 Mar; 6():22966. PubMed ID: 26965643
[TBL] [Abstract][Full Text] [Related]
25. Targeting the Wnt/β-catenin signaling pathway in cancer.
Zhang Y; Wang X
J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
[TBL] [Abstract][Full Text] [Related]
26. The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer.
Cai C; Zhu X
Mol Med Rep; 2012 May; 5(5):1191-6. PubMed ID: 22367735
[TBL] [Abstract][Full Text] [Related]
27. Targeting the Wnt/β-catenin signaling pathway in human cancers.
Yao H; Ashihara E; Maekawa T
Expert Opin Ther Targets; 2011 Jul; 15(7):873-87. PubMed ID: 21486121
[TBL] [Abstract][Full Text] [Related]
28. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging.
Yeh CT; Rao YK; Ye M; Wu WS; Chang TC; Wang LS; Wu CH; Wu AT; Tzeng YM
Toxicol Appl Pharmacol; 2012 May; 261(1):31-41. PubMed ID: 22465936
[TBL] [Abstract][Full Text] [Related]
29. Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype.
Jang GB; Kim JY; Cho SD; Park KS; Jung JY; Lee HY; Hong IS; Nam JS
Sci Rep; 2015 Jul; 5():12465. PubMed ID: 26202299
[TBL] [Abstract][Full Text] [Related]
30. MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer.
Zhan T; Ambrosi G; Wandmacher AM; Rauscher B; Betge J; Rindtorff N; Häussler RS; Hinsenkamp I; Bamberg L; Hessling B; Müller-Decker K; Erdmann G; Burgermeister E; Ebert MP; Boutros M
Nat Commun; 2019 May; 10(1):2197. PubMed ID: 31097693
[TBL] [Abstract][Full Text] [Related]
31. Wnt/β-catenin pathway mediates (-)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells.
Zhu J; Jiang Y; Yang X; Wang S; Xie C; Li X; Li Y; Chen Y; Wang X; Meng Y; Zhu M; Wu R; Huang C; Ma X; Geng S; Wu J; Zhong C
Biochem Biophys Res Commun; 2017 Jan; 482(1):15-21. PubMed ID: 27836540
[TBL] [Abstract][Full Text] [Related]
32. A perspective on medicinal chemistry approaches towards adenomatous polyposis coli and Wnt signal based colorectal cancer inhibitors.
Phull MS; Jadav SS; Gundla R; Mainkar PS
Eur J Med Chem; 2021 Feb; 212():113149. PubMed ID: 33445154
[TBL] [Abstract][Full Text] [Related]
33. A mutant KRAS-induced factor REG4 promotes cancer stem cell properties via Wnt/β-catenin signaling.
Hwang JH; Yoon J; Cho YH; Cha PH; Park JC; Choi KY
Int J Cancer; 2020 May; 146(10):2877-2890. PubMed ID: 31605540
[TBL] [Abstract][Full Text] [Related]
34. Targeting CDK12 obviates the malignant phenotypes of colorectal cancer through the Wnt/β-catenin signaling pathway.
Liu S; Wu J; Lu X; Guo C; Zheng Q; Wang Y; Hu Q; Bian S; Luo L; Cheng Q; Liu Z; Dai W
Exp Cell Res; 2023 Jul; 428(1):113613. PubMed ID: 37100369
[TBL] [Abstract][Full Text] [Related]
35. SRI36160 is a specific inhibitor of Wnt/β-catenin signaling in human pancreatic and colorectal cancer cells.
Li Y; Oliver PG; Lu W; Pathak V; Sridharan S; Augelli-Szafran CE; Buchsbaum DJ; Suto MJ
Cancer Lett; 2017 Mar; 389():41-48. PubMed ID: 28043913
[TBL] [Abstract][Full Text] [Related]
36. Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms.
Novellasdemunt L; Antas P; Li VS
Am J Physiol Cell Physiol; 2015 Oct; 309(8):C511-21. PubMed ID: 26289750
[TBL] [Abstract][Full Text] [Related]
37. Combination Therapy of Lactobacillus plantarum Supernatant and 5-Fluouracil Increases Chemosensitivity in Colorectal Cancer Cells.
An J; Ha EM
J Microbiol Biotechnol; 2016 Aug; 26(8):1490-503. PubMed ID: 27221111
[TBL] [Abstract][Full Text] [Related]
38. Emerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancer.
Sabatino L; Pancione M; Votino C; Colangelo T; Lupo A; Novellino E; Lavecchia A; Colantuoni V
World J Gastroenterol; 2014 Jun; 20(23):7137-51. PubMed ID: 24966585
[TBL] [Abstract][Full Text] [Related]
39. Blocking the Wnt/β‑catenin signaling pathway to treat colorectal cancer: Strategies to improve current therapies (Review).
Chen Y; Chen M; Deng K
Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36579676
[TBL] [Abstract][Full Text] [Related]
40. Origin of Somatic Mutations in β-Catenin versus Adenomatous Polyposis Coli in Colon Cancer: Random Mutagenesis in Animal Models versus Nonrandom Mutagenesis in Humans.
Yang D; Zhang M; Gold B
Chem Res Toxicol; 2017 Jul; 30(7):1369-1375. PubMed ID: 28578586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
